Position Overview:
We are building a best-in-class Field Medical organization as a natural next step in the growth of our Medical Affairs organization at Beam therapeutics! This Director (or Associate Director) level MSL will own a defined US territory with primary responsibility in sickle cell disease (SCD) and shared accountability across the Beam pipeline, including Alpha-1 antitrypsin deficiency (Alpha-1) and glycogen storage disease 1a (GSD). You will architect territory strategy, onboard priority treatment centers, engage KOLs and HCPs, generate actionable insights, and drive pre-commercial launch readiness in close collaboration with cross-functional partners.
Responsibilities:
• Develop and execute territory strategy: map treatment centers, referral networks, transplant/infusion sites, cell-collection capabilities, payers, and advocacy groups; prioritize accounts and set measurable objectives. • Support treatment center onboarding: coordinate scientific and operational readiness aligned with SOPs, compliance, and patient journey requirements; partner with internal teams for qualification and activation. • Build trusted relationships with KOLs and HCPs: deliver fair-balanced, evidence-based education on rare diseases, cell and gene therapy science, and Beam's platform; foster advocacy and awareness. • Educate stakeholders on disease state, therapeutic landscape, and company platform to drive awareness and credibility in the rare disease and CGT space. • Generate high-quality insights from field interactions: synthesize trends and communicate actionable recommendations to Medical Affairs leadership and cross-functional partners. • Collaborate on pre-launch planning: align with Medical Strategy, Publications, Medical Information, Value & Evidence, and Medical Operations to ensure scientific messaging, data dissemination, and field tools are ready for first commercial launch. • Support clinical research activities: identify potential sites, assist with feasibility assessments, and promote best practices for enrollment and retention while maintaining medical/scientific independence. • Partner cross-functionally with Commercial, Market Access, and Clinical teams while preserving medical independence; coordinate account plans to ensure seamless patient access and avoid duplication. • Represent the company at congresses and external scientific meetings: plan and execute presence, engage in meaningful scientific exchanges, and follow up to strengthen visibility and credibility. • Provide education and resources to treatment centers on operational readiness for advanced therapies, including apheresis and cell-handling processes. • Serve as a trusted resource for compliance and ethical standards: ensure all interactions and materials meet company policies, regulatory requirements, and industry codes. • Maintain operational excellence: document activities and insights in CRM, monitor KPIs, and continuously improve processes, content, and tools. • Prepare and deliver training for internal teams and external stakeholders on rare disease management and CGT fundamentals to support launch readiness. • Act as a scientific ambassador for the company: articulate the value of the platform and pipeline to diverse audiences including clinicians, researchers, and advocacy groups. • Monitor evolving evidence and competitive landscape in rare disease and CGT; share updates internally to inform strategy and decision-making.
Qualifications:
Advanced scientific degree (PharmD, PhD, MD, or equivalent). ~10+ years industry experience in Medical Affairs with significant Field Medical tenure. Rare disease expertise required; hematology strongly preferred with emphasis on SCD. Small biotech experience preferred; demonstrated impact in resource-constrained settings. Launch experience (pre-approval to post-launch), ideally in CGT or complex specialty (buy-and-bill) environments. Proven territory management and account planning capability across complex ecosystems (academic centers, community networks, payers, advocacy). Independent, proactive operator with strong ownership. Cross-functional collaboration with Clinical, Regulatory, Commercial, Medical Operations, and Publications while maintaining medical/scientific integrity. Outstanding communication skills; ability to translate complex science into clear, credible narratives. Analytical strength for insight collection, synthesis, and actionable recommendations. Travel up to ~60% across assigned territory.